nevirapine has been researched along with thiazolidines in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arakaki, R; Baba, M; Jinno, S; Nakashima, H; Premanathan, M; Ramanan, S; Yamashita, S | 1 |
Eleftheriou, P; Geronikaki, A; Mehta, VP; Pitta, E; Surmava, S; Van der Eycken, EV | 1 |
2 other study(ies) available for nevirapine and thiazolidines
Article | Year |
---|---|
3-(5-Dimethylamino-1-naphthalenesulphonyl)-2-(3-pyridyl)thiazolidine (YHI-1) selectively inhibits human immunodeficiency virus type 1.
Topics: Animals; Anti-HIV Agents; Antiviral Agents; Cell Line; Cysteine; Drug Resistance; Fishes; HIV Core Protein p24; HIV Protease; HIV-1; Humans; Molecular Structure; Naphthalenes; Nevirapine; Reverse Transcriptase Inhibitors; Thiazoles; Thiazolidines; Virus Replication | 1998 |
Synthesis and HIV-1 RT inhibitory action of novel (4/6-substituted benzo[d]thiazol -2-yl)thiazolidin-4-ones. Divergence from the non-competitive inhibition mechanism.
Topics: Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; HIV Reverse Transcriptase; Inhibitory Concentration 50; Kinetics; Molecular Docking Simulation; Nevirapine; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiazolidines; Toxicity Tests | 2013 |